HAVAH Therapeutics

📍 North Adelaide, Australia🗓 Founded 2005👥 6 employees💰 Last funded Sep 2023
Biotechnology🌐 havahtx.com
Website LinkedIn
HavaH’s mission is to develop therapies with reduced side effects and early prevention of breast cancers including hormonal refractory ER+ breast cancer and metastatic cancer. Havah uses targeted modulation of the hormonal balance in the breast to achieve a more nuanced hormonal regulation than traditional hormonal therapies. HavaH is developing innovative, proprietary hormonal therapies that aim to improve quality of life for women across the world. HavaH brings together a world-class team passionate about helping women live lives free from the suffering caused by breast pain, debilitating menopausal symptoms and breast cancer. Havah has extensive clinical experience with T+Ai™ having generated data from more than 1,000 Australian women with breast disease through an ongoing open label cohort study, with critical safety pharmacokinetic and early efficacy data already demonstrated.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2005
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in HAVAH Therapeutics?
HAVAH Therapeutics has 1 investors on record on gritt.io.
When did HAVAH Therapeutics last raise funding?
The most recent investment in HAVAH Therapeutics recorded on gritt.io was in September 2023.
When was HAVAH Therapeutics founded?
HAVAH Therapeutics was founded in 2005.
What industry is HAVAH Therapeutics in?
HAVAH Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is HAVAH Therapeutics based?
HAVAH Therapeutics is headquartered in North Adelaide, Australia.